Lymphatic therapy by Godoy method in the treatment of dyspnea after COVID- 19: case report
Journal: Medicni perspektivi (Vol.27, No. 2)Publication Date: 2022-06-28
Authors : Jose Maria Pereira de Godoy Livia Maria Pereira de Godoy;
Page : 181-183
Keywords : dyspnea; sequela; COVID-19; Godoy method®;
Abstract
Despite all efforts, this disease has been a major cause of mortality as well as sequelae after the infectious event. Issues regarding an effective form of treatment for the virus have led to efforts focused on the acute manifestations of the disease. The aim of the present study is to describe the first observational result of the treatment of a pulmonary sequela of COVID-19 with important symptomatic limitations. One month ago, the patient contracted COVID-19 and was treated clinically, but the case progressed with important respiratory and physical limitations. An increase occurred in the lymphedema and the patient sought treatment. She would waken at night with dyspnea and was unable to walk more than a few steps or climb stairs. Intensive treatment of the lymphedema was proposed using the Godoy Method®. The Godoy method for reversing fibrosis was useful in improving dyspnea in a short period of time in a patient with sequelae resulting from COVID-19.
Other Latest Articles
- Diagnostic potentials of modern radiothermometry in oncomammological practice
- Study of the seasonal dynamics tendencies of sales of substitution therapy medications for dry-eye syndrome treatment in Ukraine
- Strategy for the development of the public health system of Ukraine in line with modern changes in society
- Role of brain-derived neurotrophic factor in coping with the consequences of psychotraumatic events
- Sanitary and hygienic characteristics of potassium stearate as a source of anthropogenic pollution of water reservoirs
Last modified: 2022-07-08 18:24:38